New immunisation reference page: Open disclosure

Open disclosure is an accreditation requirement of all health services under the National Safety and Quality Health Service (NSQHS) Standards.  Open disclosure should occur after any vaccine error, and includes a discussion with the affected person, or their families, carers or other support persons. Open disclosure can be challenging and complex. However, it can produce benefits such as improved transparency and communication between clinicians and patients; and opportunities for health services to improve care delivery systems and processes. 

MVEC has recently published a new immunisation reference page on Open disclosure.  

MVEC: Open disclosure 


New home for COVID-19 information

Coronavirus (COVID-19) Victoria has now moved all COVID-19 information to a new home on the Better Health Channel. Check the website for consumer and clinician information on disease prevention, testing, treatment, long covid, and special risk group advice.  

Better Health: Coronavirus (COVID-19) Victoria 


Cases of measles rising around the world

Rates of measles have been rising around the world. There were 127 cases in the United Kingdom in January 2024, leading the UK Health Security Agency to declare a National Incident. 

In Australia, there were 5 confirmed measles cases in January 2024. This includes 3 in Victoria, 1 in ACT and 1 in Queensland.  

The World Health Organization (WHO) reported a 30-fold increase in measles cases across Europe from 2022 to 2023. 

These data remind us of the importance of achieving and maintaining over 95% coverage with 2 doses of measles-containing vaccine. 

MVEC: Measles 


New Australian CDC

Australia now has its very own Centre for Disease Control (CDC). 

Headed by Prof Paul Kelly, the interim Australian CDC launched on 1 January 2024 within the Department of Health and Aged Care. The Australian CDC aims to enhance Australia’s health emergency planning and preparedness, strengthen partnerships with stakeholders and provide transparent and consistent public health advice. 

Find out more at the Australian Centre for Disease Control website. 


WHO: New polio cases in Indonesia

In December 2023, the Indonesian Ministry of Health notified WHO of two confirmed cases of circulating vaccine-derived poliovirus type 2 (cVDPV2) in Java (Central and East). 

Two environmental samples taken in East Java were also positive for cVDPV2 in December 2023.  Four cases of cVDPV2 infection were reported earlier in 2023 in Aceh province and West Java. 

To read more, visit WHO: Disease Outbreak News 


Victorian Department of Health: Japanese encephalitis vaccine program

Japanese encephalitis virus (JEV) is a rare but potentially serious infection caused by the flavivirus. It is spread to humans through mosquito bites. 

Due to recent high rainfall and flooding across large areas of Victoria, the Victorian Department of Health is reminding people to take precautions against mosquito bites, and to get vaccinated if at high risk of exposure to the virus. 

Victorian Department of Health: Japanese encephalitis 


Launch of National Immunisation Program Vaccinations in Pharmacy (NIPVIP) program

The Australian government’s National Immunisation Program Vaccinations in Pharmacy (NIPVIP) program commenced on 1 January 2024. 

The NIPVIP allows individuals aged 5 years and over to receive scheduled NIP vaccines in a community pharmacy at no financial cost. 

Read more about NIPVIP on the Department of Health and Aged Care website and the Pharmacy Programs Administrator website. 


TGA: New RSV vaccine

Respiratory syncytial virus (RSV) is one of the leading causes of respiratory tract infections in young children and is associated with severe respiratory disease in people aged over 60 years. 

In January 2024, AREXVY was registered by the Therapeutic Goods Administration (TGA) for the immunisation of people aged 60 years and older to prevent lower respiratory tract disease caused by RSV. AREXVY is a recombinant respiratory syncytial virus pre-fusion F protein vaccine. Guidance on its use is yet to come. 

TGA: Guidance and resources on AREXVY 


Updated immunisation reference page: Q fever

We have recently updated our Q fever reference page. 

Q fever is caused by infection with the bacteria Coxiella burnetii.  People at highest risk of exposure are those in close contact with animals and animal products. Despite being a vaccine-preventable disease, there are around 500 cases of Q fever reported across Australia every year. 

The updated page provides greater detail on what Q fever is, its symptoms, complications, epidemiology and prevention. 

MVEC: Q fever